Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Eyal Attar, MD	None	Celgene Corporation; Pharmion Corporation	None	None	3/31/2008
John M. Bennett, MD	None	Novartis Pharmaceuticals Corporation	None	Celgene Corporation; Johnson & Johnson; Pharmion Corporation; Telik, Inc.	7/7/2009
Clara D. Bloomfield, MD	None	None	None	None	9/28/2009
Carlos M. De Castro, MD	Celgene Corporation; Cephalon, Inc.; Pharmion Corporation	Alexion Pharmaceuticals, Inc.; Celgene Corporation; Jannsen Pharmaceutica Products, LP; Pharmion Corporation	None	None	7/7/2009
H. Joachim Deeg, MD	None	None	None	None	9/28/2009
Harry P. Erba, MD, PhD	Cephalon, Inc.; Eli Lilly and Company; Exelixis Inc.; Genzyme Corporation; Kanisa Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Wyeth Pharmaceuticals; Xanthus Pharmacueuticals, Inc.	Bristol-Myers Squibb Company; Celgene Corporation; Cephalon, Inc.; Genzyme Corporation; MGI PHARMA, INC.; Novartis Pharmaceuticals Corporation; Pharmion Corporation	None	National Cancer Institute	11/17/2009
James M. Foran, MD	Genzyme Corporation; Ambit BioSciences; Astex Therapeutics; Seattle Genetics	Celgene Corporation; Genzyme Corporation; Astex Therapeutics	None	None	10/28/2009
Karin Gaensler, MD					Pending
Lauren Gallagher, PhD	None	None	None	None	8/28/2009
Guillermo Garcia-Manero, MD	Celgene Corporation; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation	Merck & Co., Inc.; MGI PHARMA, INC.; Novartis Pharmaceuticals Corporation; Pharmion Corporation	None	None	7/28/2009
Steven D. Gore, MD	Celgene Corporation; Johnson & Johnson	Celgene Corporation	Celgene Corporation	None	10/21/2009
Peter L. Greenberg, MD	Amgen Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation	Celgene Corporation; Novartis Pharmaceuticals Corporation	None	None	10/16/2009
Kristina M Gregory, RN, MSN, OCN	None	None	None	None	8/21/2009
David Head, MD	None	None	None	None	8/19/2009
Rashmi Kumar, PhD	None	None	None	None	7/1/2009
Lori J. Maness, MD	None	None	None	None	10/28/2009
Joan S McClure, MS	None	None	None	None	9/28/2009
Michael M. Millenson, MD, FACP	None	Celgene Corporation; GlaxoSmithKline; MGI PHARMA, INC.; Pharmion Corporation	None	sanofi-aventis U.S.	10/28/2009
Tariq I. Mughal, MD, FRCP	Celgene Corporation; Novartis Pharmaceuticals Corporation	Bristol-Myers Squibb Company; Celgene Corporation; Novartis Pharmaceuticals Corporation	None	None	10/7/2009
Stephen D. Nimer, MD	Celgene Corporation; MGI PHARMA, INC.	Eisai Inc.	None	None	10/3/2008
Margaret R. O'Donnell, MD	Eisai Inc.	Celgene Corporation; Eisai Inc.; Genzyme Corporation	None	None	11/16/2009
Hussain I. Saba, MD, PhD	None	None	None	None	7/21/2008
Paul J. Shami, MD	Genzyme Corporation	Novartis Pharmaceuticals Corporation	JSK Therapeutics Inc.	None	10/28/2009
Dorothy Shead, MS	None	None	None	None	9/29/2009
Richard M. Stone, MD	Bristol-Myers Squibb Company; Celgene Corporation; Novartis Pharmaceuticals Corporation	Celgene Corporation; Eisai Inc.; Genzyme Corporation; ImClone Systems Incorporated; Merck & Co., Inc.	None	None	10/28/2009
Martin S. Tallman, MD	None	Genzyme Corporation	None	None	10/28/2009
James E. Thompson, MD	None	None	None	None	11/9/2009
Peter Westervelt, MD, PhD	None	Celgene Corporation; Novartis Pharmaceuticals Corporation	None	None	10/6/2009

NCCN Website Supporters